戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion therapy was as effective as the Halsted radical mastectomy.
2 te earlier results showing no advantage from radical mastectomy.
3   Surgical therapy has varied from biopsy to radical mastectomy.
4  with radical, extended radical, or modified radical mastectomy.
5   Patients underwent a radical or a modified radical mastectomy.
6 atients) and less likely to undergo modified radical mastectomy (25% vs 47% of the Pt/PhysD breast ca
7 y with axillary node dissection, or modified radical mastectomy (73% overall); adjuvant therapy was d
8 s were randomized to radical versus modified radical mastectomy, and node-positive patients were also
9 breast cancer treated by BCT versus modified radical mastectomy are reported to be equivalent in pros
10 sk patients, such as anti-estrogen drugs and radical mastectomy, are limited by lack of efficacy, und
11     In women with breast cancer, the role of radical mastectomy, as compared with less extensive surg
12                                  The Halsted radical mastectomy, first popularized in 1894, was perfo
13 nd concurrent radiation (RT) before modified radical mastectomy followed by adjuvant doxorubicin-base
14 mastectomy compared with radical or modified radical mastectomy, IMN dissection was largely abandoned
15 t cancer, with emphasis on costs of modified radical mastectomy (MRM) compared with breast-conserving
16 s had previously undergone either a modified radical mastectomy (MRM) or a segmental mastectomy with
17        Patients who had undergone a modified radical mastectomy or a total mastectomy with low-axilla
18                                        After radical mastectomy or for unresectable tumors despite ne
19 lly positive axillary nodes either underwent radical mastectomy or underwent total mastectomy without
20 e by incisional biopsy, followed by modified radical mastectomy performed after a 30-day treatment wi
21 entury, the aggressive surgical procedure of radical mastectomy to treat breast cancer was proposed b
22 clinically negative axillary nodes underwent radical mastectomy, total mastectomy without axillary di
23 diation as compared with those who underwent radical mastectomy was 1.03 (95 percent confidence inter
24 diation as compared with those who underwent radical mastectomy was 1.06 (95 percent confidence inter
25 diation as compared with those who underwent radical mastectomy was 1.08 (95 percent confidence inter
26                                     Modified radical mastectomy was performed at least 2 weeks after
27                                     Modified radical mastectomy was performed in 18 of the 22 patient
28  systemic therapy [NST] followed by modified radical mastectomy without immediate reconstruction and
29 t guideline-concordant surgery (ie, modified radical mastectomy without immediate reconstruction with